Literature DB >> 3258204

B cell repertoire for anti-DNA antibody in normal and lupus mice: differential expression of precursor cells for high and low affinity anti-DNA antibodies.

T Tsubata1, S Nishikawa, Y Katsura, S Kumagai, H Imura.   

Abstract

The precursor frequency for anti-DNA antibody producing cells and the affinity of antibodies secreted by these cells in both immature prereceptor B cell populations and mature B cell populations were compared between 8-week-old C57BL/6 female mice and 9-month-old B/WF1 female mice by producing a large collection of IgM secreting hybridomas from LPS-stimulated B cells. The data indicate that precursor cells for high affinity anti-DNA antibody are eliminated as they mature in C57BL/6 mice, while a sizable number of such clones are present in mature splenic B cells of aged B/WF1 mice. These results suggest that the emergence of precursors for high affinity anti-DNA producing cells in mature B cell population is an important factor in the pathogenesis of SLE.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258204      PMCID: PMC1541635     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Immunological regulation of spontaneous antibodies to DNA and RNA. II. Sequential switch from IgM to IgG in NZB/NZW F1 mice.

Authors:  R Papoian; R Pillarisetty; N Talal
Journal:  Immunology       Date:  1977-01       Impact factor: 7.397

2.  The kinetics of antibody production and affinity in BALB-c mice immune and partially tolerant to the 2,4-dinitrophenyl determinant.

Authors:  A R Pickard; H F Havas
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

Review 3.  Cell selection by antigen in the immune response.

Authors:  G W Siskind; B Benacerraf
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

4.  Genetic studies of autoimmunity in New Zealand mice. III. Associations among anti-DNA antibodies, NTA, and renal disease in (NZB x NZW)F1 x NZW backcross mice.

Authors:  H Yoshida; A Kohno; K Ohta; S Hirose; N Maruyama; T Shirai
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

5.  Immature B cells as the target for in vivo tolerance induction.

Authors:  N R Klinman; A F Schrater; D H Katz
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

6.  A double antibody solid phase assay for DNA autoantibodies for clinical use.

Authors:  A Lange; I M Roitt; D Doniach
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

7.  Clonotypic comparison of IgG anti-DNA antibodies of healthy subjects and systemic lupus erythematosus patients: studies on heterogeneity and avidity.

Authors:  M Yoshida; H Yoshida; E Muso; T Tamura; T Shimada; C Kawai; Y Hamashima
Journal:  Immunol Lett       Date:  1987-06       Impact factor: 3.685

8.  Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.

Authors:  J B Winfield; I Faiferman; D Koffler
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

9.  The in vitro and in vivo induction of anti-double-stranded DNA antibodies in normal and autoimmune mice.

Authors:  F Fish; M Ziff
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

10.  Changes in immunoglobulin class and subclass of anti-DNA antibodies with increasing age in N/ZBW F1 hybrid mice.

Authors:  M W Steward; F C Hay
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

View more
  2 in total

1.  Qualitative difference of anti-DNA antibody-producing cell precursors in the pre-immune B cell repertoire between normal and lupus-prone mice.

Authors:  K Iwai; T Tsubata; Y Katsura; S Kumagai; H Imura
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

2.  Neonatal exposure to thymotropic gross murine leukemia virus induces virus-specific immunologic nonresponsiveness.

Authors:  J M Korostoff; M T Nakada; S J Faas; K J Blank; G N Gaulton
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.